ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 2nd April, 2020 on account of Ram Navami.

ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0%
Tue, 12 Feb

ASTRAZENECA PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

ASTRAZENECA PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m1,2851,6142,15233.4%67.4%
Other incomeRs m2734354.2%29.2%
TurnoverRs m1,3121,6472,18732.8%66.6%
ExpensesRs m1,3941,4661,74318.9%25.1%
Gross profitRs m-108148409176.9%
DepreciationRs m3737382.9%1.4%
InterestRs m0000.0%0.0%
Profit before taxRs m-118144406181.1%
TaxRs m-1553115116.5%
Profit after taxRs m-10491291218.6%
Gross profit margin%-8.49.119.0
Effective tax rate%12.436.828.3
Net profit margin%-7.95.513.3
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 67.4% on a year-on-year (YoY) basis. The expenses were up by 25.1% YoY during the same period.
  • The company's operating profit declined by 478.8% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 19.0% in 3QFY19 as against 8.4% in 3QFY18.
  • Depreciation charges increased by 1.4% and finance costs increased by 0.0% YoY, respectively.
  • Other income increased by 29.2% YoY during the quarter.
  • Net profit for the quarter increased by 381.0% YoY. Net profit margins during the quarter increased from -7.9% in 3QFY18 to 13.3% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 33.4% on a quarter-on-quarter (QoQ) basis. The expenses were up by 18.9% QoQ during the same period.
  • The company's operating profit increased by 176.9% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 19.0% in 3QFY19 as against 9.1% in 2QFY18.
  • Net profit for the quarter increased by 218.6% QoQ, while net profit margins increased from 5.5% in 2QFY18 to 13.3% in 3QFY19.

To see how ASTRAZENECA PHARMA has performed over the last eight quarters, please visit here.

ASTRAZENECA PHARMA Share Price Performance

Over the last one year, ASTRAZENECA PHARMA share price has moved up from Rs 1,050.4 to Rs 1,847.0, registering a Gain of Rs 796.6 or around 75.8%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,718.3 (down 0.0%). Over the last one year it has moved down from 14,517.2 to 13,718.3, a gain of 799 points (down 5.5%).

Overall, the S&P BSE SENSEX is up 6.1% over the year.

Current Valuations

At the current price of Rs 1,847.0, the price to earnings (P/E) ratio of ASTRAZENECA PHARMA stands at 96.5 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 26.9 times.

Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 381.0%". Click here!

  

Related Views on News

SYNGENE INTERNATIONAL Surges by 7%; BSE HEALTHCARE Index Up 0.2% (Market Updates)

Apr 1, 2020 | Updated on Apr 1, 2020

SYNGENE INTERNATIONAL share price has surged by 7% and its current market price is Rs 245. The BSE HEALTHCARE is up by 0.2%. The top gainers in the BSE HEALTHCARE Index are SYNGENE INTERNATIONAL (up 7.2%) and ASTRAZENECA PHARMA (up 7.3%). The top losers are IPCA LABS (down 0.3%) and APOLLO HOSPITALS (down 0.7%).

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

ASTRAZENECA PHARMA SHARE PRICE


Apr 1, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA - MYLAN COMPARISON

COMPARE ASTRAZENECA PHARMA WITH

MARKET STATS